Primary prevention of cardiovascular disease in people living with HIV: a clinical update.
作者信息
Ratnapalan Mohana, Lindsey Benjamin B, Greig Julia
机构信息
Centre for Academic Primary Care, School of Medicine, University of Nottingham, Nottingham.
Clinical Research Training Fellow and Specialty Registrar in Infectious Disease and Virology, Division of Medicine, University of Sheffield, Sheffield; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield.
出版信息
Br J Gen Pract. 2024 Aug 29;74(746):428-429. doi: 10.3399/bjgp24X739389. Print 2024 Sep.
Abstract
摘要
相似文献
1
Primary prevention of cardiovascular disease in people living with HIV: a clinical update.HIV感染者心血管疾病的一级预防：临床最新进展
Br J Gen Pract. 2024 Aug 29;74(746):428-429. doi: 10.3399/bjgp24X739389. Print 2024 Sep.
2
Cardiovascular Risk in People Living with HIV: A Preliminary Case Study from Romania.罗马尼亚HIV感染者的心血管风险：一项初步案例研究。
Medicina (Kaunas). 2025 Aug 15;61(8):1468. doi: 10.3390/medicina61081468.
3
Statin Therapy as Primary Prevention for Persons With HIV: A Synopsis of Recommendations From the U.S. Department of Health and Human Services Antiretroviral Treatment Guidelines Panel.他汀类药物治疗作为HIV感染者的一级预防：美国卫生与公众服务部抗逆转录病毒治疗指南小组建议概述
Ann Intern Med. 2025 Jun;178(6):847-857. doi: 10.7326/ANNALS-24-03564. Epub 2025 May 27.
4
Performance of the pooled cohort equations and D:A:D risk scores among individuals with HIV in a global cardiovascular disease prevention trial: a cohort study leveraging data from REPRIEVE.在一项全球心血管疾病预防试验中，对感染艾滋病毒个体应用汇总队列方程和D:A:D风险评分的情况：一项利用REPRIEVE研究数据的队列研究
Lancet HIV. 2025 Feb;12(2):e118-e129. doi: 10.1016/S2352-3018(24)00276-5. Epub 2025 Jan 17.
5
Hepatic steatosis and nonalcoholic fatty liver disease are common and associated with cardiometabolic risk in a primary prevention cohort of people with HIV.肝脂肪变性和非酒精性脂肪性肝病在艾滋病毒感染者的一级预防队列中很常见，并与心血管代谢风险相关。
AIDS. 2023 Nov 15;37(14):2149-2159. doi: 10.1097/QAD.0000000000003671. Epub 2023 Jul 27.
6
Diabetes Risk Factors in People With HIV Receiving Pitavastatin Versus Placebo for Cardiovascular Disease Prevention : A Randomized Trial.接受匹伐他汀与安慰剂治疗以预防心血管疾病的 HIV 感染者的糖尿病风险因素：一项随机试验。
Ann Intern Med. 2024 Nov;177(11):1449-1461. doi: 10.7326/ANNALS-24-00944. Epub 2024 Oct 8.
7
Risk Factors for Major Adverse Cardiovascular Events in Antiretroviral Therapy-Treated People with HIV: A Long-Term Cohort Study in Turkey.接受抗逆转录病毒治疗的HIV感染者发生主要不良心血管事件的危险因素：土耳其的一项长期队列研究
AIDS Patient Care STDS. 2025 Sep;39(9):342-352. doi: 10.1177/10872914251359817. Epub 2025 Jul 18.
8
Periodontal therapy for primary or secondary prevention of cardiovascular disease in people with periodontitis.牙周炎患者牙周病的一级或二级预防的牙周治疗。
Cochrane Database Syst Rev. 2022 Oct 4;10(10):CD009197. doi: 10.1002/14651858.CD009197.pub5.
9
Low glycaemic index diets for the prevention of cardiovascular disease.低升糖指数饮食对心血管疾病的预防作用
Cochrane Database Syst Rev. 2017 Jul 31;7(7):CD004467. doi: 10.1002/14651858.CD004467.pub3.
10
Prevalence and predictors of cardiovascular disease risk among people living with human immunodeficiency virus in Nigeria.尼日利亚人类免疫缺陷病毒感染者心血管疾病风险的患病率及预测因素
AIDS Res Ther. 2025 Aug 22;22(1):80. doi: 10.1186/s12981-025-00786-w.
本文引用的文献
1
Clinical Outcomes After Acute Coronary Syndromes or Revascularization Among People Living With HIV: A Systematic Review and Meta-Analysis.HIV 感染者急性冠状动脉综合征或血运重建后的临床结局：系统评价和荟萃分析。
JAMA Netw Open. 2024 May 1;7(5):e2411159. doi: 10.1001/jamanetworkopen.2024.11159.
2
Longitudinal trends in causes of death among adults with HIV on antiretroviral therapy in Europe and North America from 1996 to 2020: a collaboration of cohort studies.1996 年至 2020 年期间，在接受抗逆转录病毒治疗的欧洲和北美的艾滋病毒感染者中，导致死亡的原因的纵向趋势：队列研究的合作。
Lancet HIV. 2024 Mar;11(3):e176-e185. doi: 10.1016/S2352-3018(23)00272-2. Epub 2024 Jan 24.
3
Pitavastatin to Prevent Cardiovascular Disease in HIV Infection.匹伐他汀预防 HIV 感染患者的心血管疾病。
N Engl J Med. 2023 Aug 24;389(8):687-699. doi: 10.1056/NEJMoa2304146. Epub 2023 Jul 23.
4
Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies.2015 年后在欧洲和北美接受长期抗逆转录病毒治疗的艾滋病毒感染者的预期寿命：队列研究的协作分析。
Lancet HIV. 2023 May;10(5):e295-e307. doi: 10.1016/S2352-3018(23)00028-0. Epub 2023 Mar 20.
5
Performance of Cardiovascular Risk Prediction Models Among People Living With HIV: A Systematic Review and Meta-analysis.HIV 感染者心血管风险预测模型的性能：系统评价和荟萃分析。
JAMA Cardiol. 2023 Feb 1;8(2):139-149. doi: 10.1001/jamacardio.2022.4873.
6
Global Burden of Atherosclerotic Cardiovascular Disease in People Living With HIV: Systematic Review and Meta-Analysis.全球艾滋病毒感染者的动脉粥样硬化性心血管疾病负担：系统评价和荟萃分析。
Circulation. 2018 Sep 11;138(11):1100-1112. doi: 10.1161/CIRCULATIONAHA.117.033369.
Zotero 插件